FindTrial
Sign In

STUDY OF EFFECT OF ADDING DEXMEDETOMIDINE VERSUS CLONIDINE AS ADJUVANTS TO BUPIVACAINE IN ULTRASOUND GUIDED SUPRACLAVICULAR BLOCK

A RANDOMIZED , DOUBLE BLIND STUDY OF EFFECT OF ADDING DEXMEDETOMIDINE VERSUS CLONIDINE AS ADJUVANTS TO BUPIVACAINE IN ULTRASOUND GUIDED SUPRACLAVICULAR BLOCK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044197
Enrollment
80
Registered
2022-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bupivacaine plus Dexemedetomidine: 20 ml of 0.5% Bupivacaine and 5 mcg of Dexemedetomidine Single Injection Control Intervention1: Bupivacaine plus Clonidine: 20 ml of 0.5% Bupivacaine

Sponsors

Dr Niveditha B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to give written informed consent. 2.ASA physical status I and II patients. 3.Patients undergoing elective upper limb surgeries. 4.Patients with Body Mass Index between 18 to 30 kg/m2

Exclusion criteria

Exclusion criteria: 1.Patients with pre-existing neurological disorder. 2.Patients with hypersensitivity to drug. 3.Inadequate block. 4.History of coagulopathy or anticoagulants treatment.

Design outcomes

Primary

MeasureTime frame
To evaluate the onset and duration of sensory and motor blockade. Timepoint: Sensory and Motor Blockade -3 minutes,6 minutes,9 minutes,12 minutes,15 minutes,18 minutes, 21 minutes,27 minutes and 30 minutes. Sedation - 10 minutes,30 minutes, 60 minutes,120 minutes,240 minutes,360 minutes and 720 minutes.—

Secondary

MeasureTime frame
To evaluate haemodynamic variablesTimepoint: 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes.—

Countries

India

Contacts

Public ContactDr Ramesh Kumar PB

BGS Global Institute of Medial Sciences

nivibasuraj94@gmail.com9590377700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026